液相色谱-离子阱质谱法测定人血清中莫西沙星浓度 |
| |
引用本文: | 陈漪,;施家威,;金米聪. 液相色谱-离子阱质谱法测定人血清中莫西沙星浓度[J]. 中国临床药学杂志, 2009, 0(6): 345-348 |
| |
作者姓名: | 陈漪, 施家威, 金米聪 |
| |
作者单位: | [1]宁波市妇女儿童医院药剂科,宁波315012; [2]宁波市疾病预防控制中心,宁波315010 |
| |
基金项目: | 宁波市自然科学基金(2007A610072) |
| |
摘 要: | 目的建立一种灵敏、可靠的检测血清中莫西沙星浓度的高效液相色谱-离子阱质谱法。方法血清样品经磷酸盐缓冲液提取后,用Waters Oasis MAX小柱进行净化,以乙腈-0.05%三氟醋酸(25:75,V/V)为流动相,采用Cloversil—C18柱(150mm×3.0mm,5μm)分离,以环丙沙星为内标,应用高效液相色谱-电喷雾离子阱质谱多离子反应监测模式(MRM)测定,莫西沙星和内标的定量离子对分别为m/z402→358和m/z332→288。结果莫西沙星和内标的绝对回收率均为83.1%→90.7%,莫西沙星质量浓度为0.5-100.0μg·L^-1具有良好线性,日内精密度〈7.2%,日间精密度〈9.8%,检出限为0.5μg·L^-1。结论本方法简便、灵敏、干扰少、特异性好,可用于莫西沙星的临床药动学研究及临床患者的血药浓度测定。
|
关 键 词: | 高效液相色谱-离子阱质谱法 固相萃取 多反应监测 莫西沙星 血清 |
Determination of concentration of moxifloxacin in human serum by high-performance liquid chromatography coupled with ion trap mass spectrometry |
| |
Affiliation: | CHEN Yi, SHI Jiawei, JIN Micong (1. Department of Pharmacy, Ningbo Women' s and Children' s Hospital, Ningbo 315012, China; 2 Ningbo Municipal Center for Disease Control and Prevention, Ningbo 315010, China) |
| |
Abstract: | AIM To develop a sensitive and accurate method for the determination of moxifloxacin in human serum by high-performance liquid chromatography coupled with ion trap mass spectrometry (HPLC-ITMS). METHODS Mter moxifloxacin in human serum was extracted by phosphate buffer, the sample was cleaned with solid-phase extraction (SPE) using Oasis MAX cartridges. The separation was performed on a Cloversil-C18 column( 150 mm × 3.0 mm, 5 μm)using the mobile phase consisting of acetonitrile- 0.05% trifluoroacetic acid (25/75, V/ V). Detection was carried out by a positive electrospray ionization in the multiple reaction monitoring (MRM) mode with the transitions of m/z 402→358 and m/z 332→288 for moxifloxacin and ciprofloxacin (an internal standard), respectively. RESULTS Calibration curve was linear within the range of 0.5 - 100.0μg·L^-1, and the extraction recoveries were from 80.5% to 86.0%. The intra-day RSD was less than 7.2%, and the inter-day RSD was less than 9.8%. The detection limit was 0.5 μg· L^-1 for moxifloxacin. CONCLUSION This method is found to be simple, sensitive, little interferential and good specificity for pharmacokinetic studies and the determination of moxifloxacin in human serum for patients. |
| |
Keywords: | HPLC-MS/MS solid-phase extraction multiple reaction monitoring moxifloxacin human |
本文献已被 维普 等数据库收录! |
|